Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Canada (Primary) | PRIMARYCAN | Univ | 1,741 | 2,636,228 | -0.02% | 0.73% | 3.26% | 7.41% | 10.34% | 22.90% |
Healthcare | HEALTHCARE | Sector | 77 | 9,302 | -0.36% | -1.23% | -2.67% | 5.24% | -2.04% | 20.64% |
Biopharmaceuticals | BIOPHARMA | SubSec | 26 | 2,067 | -0.65% | -0.81% | -6.78% | 6.34% | 0.82% | -17.59% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 11 | 962 | 0.03% | -1.23% | -13.82% | 9.41% | -0.89% | 29.29% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 3 | 367 | 2.87% | -8.21% | -40.33% | 2.29% | 9.54% | 13.28% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 11 | 962 | 0.03% | -1.23% | -13.82% | 9.41% | -0.89% | 29.29% |
Endocrinology and Metabolism Biopharmaceuticals | ENDOCRINOLOGY | SubInd | 3 | 165 | 1.49% | -2.85% | -5.54% | 26.30% | 26.30% | 26.30% |
Cardiovascular System Biopharmaceuticals | CARDIOVASCULAR | SubInd | 2 | 22 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 1 | 14 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
S&P/TSX Capped Composite | XIC:CANXIC:CAN | Benchmark | 217 | 3,139,105 | 0.09% | 0.19% | 2.18% | 6.77% | 7.18% | 26.35% |
Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 1 | 242 | -1.90% | -0.62% | 4.36% | 2.13% | -12.35% | 58.53% |
Musculoskeletal System Biopharmaceuticals | MUSCULOSKELETAL | SubInd | 1 | 153 | -1.35% | 9.36% | 8.96% | 19.43% | 19.43% | 14.64% |
* Colors indicate performance relative to the benchmark.